CONMED Market Risk Adjusted Performance
| CNMD Stock | | | USD 37.41 0.13 0.35% |
Reference data associated with the Market Risk Adjusted Performance technical indicator for CONMED. Technical inputs may vary across markets and data providers.
CONMED has current Market Risk Adjusted Performance of
-0.03.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.03 | |
| ER[a] | = | Expected return on investing in CONMED |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
CONMED Market Risk Adjusted Performance Peers Comparison
CONMED Market Risk Adjusted Performance Relative To Other Indicators
CONMED is rated
below average for market risk adjusted performance relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.